Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2026)
Bicycle Therapeutics posted quarterly FCF Margin of 7512.74% for Q1 2026, down 664099.0% year-on-year from N/an in Q1 2025, and down 17986.02% on a QoQ basis from 41.54% in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of FCF Margin data on file, last reported at 7512.74% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 664099.0% year-over-year to 7512.74%; the trailing twelve-month figure through Mar 2026 stood at 364.89% (up 34288.0% YoY), and the FY2025 full-year result was 347.21%, up 12326.0% from the prior year.
- FCF Margin for Q1 2026 stood at 7512.74%, down from 41.54% in the prior quarter.
- Across five years, FCF Margin topped out at 296.74% in Q2 2023 and bottomed at 7512.74% in Q1 2026.
- The 5-year median for FCF Margin is 612.3% (2025), against an average of 1056.63%.
- The widest annual swing landed in 2025, when FCF Margin surged 89245 bps; it then slumped 664099 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 378.06% in 2022, then sank by 135 bps to 887.99% in 2023, then soared by 70 bps to 263.32% in 2024, then surged by 84 bps to 41.54% in 2025, then tumbled by 17986 bps to 7512.74% in 2026.
- The last three FCF Margin figures came in at 7512.74% (Q1 2026), 41.54% (Q4 2025), and 612.3% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -7,512.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,512.74% |
| Dec 31, 2025 | -41.54% |
| Sep 30, 2025 | -612.30% |
| Jun 30, 2025 | -2,509.73% |
| Mar 31, 2025 | -871.75% |
| Dec 31, 2024 | -263.32% |
| Sep 30, 2024 | -1,504.75% |
| Jun 30, 2024 | -481.22% |
| Mar 31, 2024 | -681.55% |
| Dec 31, 2023 | -887.99% |
| Sep 30, 2023 | -28.53% |
| Jun 30, 2023 | 296.74% |
| Mar 31, 2023 | -990.81% |
| Dec 31, 2022 | -378.06% |
| Sep 30, 2022 | -291.28% |
| Jun 30, 2022 | -396.79% |
| Mar 31, 2022 | -807.15% |
| Dec 31, 2021 | -718.88% |
| Sep 30, 2021 | 497.32% |
| Jun 30, 2021 | -702.58% |
| Mar 31, 2021 | -792.59% |
| Dec 31, 2020 | -444.41% |
| Sep 30, 2020 | -262.36% |
| Jun 30, 2020 | -805.22% |
| Mar 31, 2020 | 1,846.06% |
| Dec 31, 2019 | -100.55% |
| Sep 30, 2019 | -1,818.89% |
| Jun 30, 2019 | -530.29% |
| Mar 31, 2019 | -88.02% |
| Dec 31, 2018 | -876.44% |
| Sep 30, 2018 | -297.14% |